


There is no fund objective available from this fund manager.
| Name | % Net Assets |
|---|---|
| Progressive | 4.9% |
| Berkshire Hathaway | 4.6% |
| Johnson & Johnson | 4.5% |
| Walgreen | 4.5% |
| Oracle Corp | 3.8% |
| Merck | 3.7% |
| Wal-Mart Stores | 3.7% |
| Baxter International | 3.7% |
| Bristol Myers Squibb | 3.6% |
| Kroger | 3.3% |
| Key | % Net Assets |
|---|---|
| 4.9% | |
| 4.6% | |
| 4.5% | |
| 4.5% | |
| 81.5% |
| Date | 20-Aug-2025 |
|---|---|
| NAV | 2,094.00p |
| Currency | GBP |
| Change | -43.00p |
| % | -2.01% |
| YTD change | 130.00p |
| YTD % | 6.62% |
| Fund Inception | n/a |
|---|---|
| Fund Manager | Mick Brewis |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | n/a |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | -0.10 |
You are here: research